1. Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, et al. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002;36(3):737–42.
2. Miller C, Tyndall M, Spittal P, Li K, Laliberte N, Schechter M. HIV incidence and associated risk factors among young injection drug users. AIDS 2002;16(3):491–93.
3. Miller CL, Spittal PM, Laliberte N, Li K, Tyndall MW, O’Shaughnessy MV, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. JAIDS 2002;30(3):335–41.
4. The Coalition of Experiential Women. Final Document from the BC Regional Strategy Meeting on Commercial Sexual Exploitation. Vancouver: April, 2003.
5. Palepu A, Tyndall MW, Leon H, Muller J, O’Shaughnessy MV, Schechter MT, et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ 2001;165(4):415–20.